Luigi Manenti
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 3
- Peptidase Inhibition and Analysis 2
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Raffaella Giavazzi (4 shared papers)Angela Garofalo (3 shared papers)Dorina Belotti (2 shared papers)Sergio Marchini (2 shared papers)Giulia Taraboletti (1 shared paper)Aung Naing (3 shared papers)Catherine Sabatos-Peyton (3 shared papers)Patrick M. Forde (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)Journal of the American Society of Nephrology (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesItalySwitzerland
In The Last Decade
Luigi Manenti
19 papers receiving 913 citations
Luigi Manenti's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 440
- Immunology 274
- Physiology 56
- Cancer Research 161
- Reproductive Medicine 61
Countries citing papers authored by Luigi Manenti
This map shows the geographic impact of Luigi Manenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Manenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Manenti more than expected).
Fields of papers citing papers by Luigi Manenti
This network shows the impact of papers produced by Luigi Manenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Manenti. The network helps show where Luigi Manenti may publish in the future.
Co-authors
The 25 scholars most cited alongside Luigi Manenti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. | 2003 | 278 |
| 2 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors Hit paper breakdown → | 2021 | 271 |
| 3 | 2011 | 69 | |
| 4 | 2022 | 54 | |
| 5 | The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically. | 2003 | 54 |
| 6 | 2004 | 50 | |
| 7 | 2018 | 38 | |
| 8 | 2019 | 34 | |
| 9 | 2005 | 25 | |
| 10 | 2013 | 22 | |
| 11 | 2016 | 8 | |
| 12 | 2022 | 5 | |
| 13 | 2012 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2019 | 2 | |
| 16 | 2023 | 1 | |
| 17 | 2013 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2023 | 1 |
About Luigi Manenti
Luigi Manenti is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Physiology, having authored 20 papers that have together received 923 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Adenosine and Purinergic Signaling (2 papers), Barrier Structure and Function Studies (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Peptidase Inhibition and Analysis (2 papers), Endometriosis Research and Treatment (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Oncology (440 citations), Immunology (274 citations), Physiology (56 citations), Cancer Research (161 citations) and Reproductive Medicine (61 citations). Luigi Manenti has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Raffaella Giavazzi, Angela Garofalo, Dorina Belotti, Sergio Marchini, Giulia Taraboletti, Aung Naing, Catherine Sabatos-Peyton, Patrick M. Forde, Hans Gelderblom and Philippe L. Bédard. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Journal of the American Society of Nephrology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.